Share this article Share this article SAN DIEGO, May 19, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Daniel J. Wolterman as independent chair of the NuVasive Board of Directors, effective immediately. Mr. Wolterman succeeds Gregory T. Lucier as the Company's Board chair, following Mr. Lucier's retirement from the Board on May 18, 2021. "As a long-standing member of our Board of Directors, Dan's expertise and leadership will help NuVasive further execute on its long-term strategy," said J. Christopher Barry, chief executive officer of NuVasive. "His extensive experience in leading large, complex healthcare organizations will be an immense asset as NuVasive continues to scale and change the lives of patients around the world."